March 2, 2005
The Clarion
Page 3
Notes from 3-2-05,3-16-05 SGA
By Daniel Cureton
Staff Writer
March 2, 2005:
There was no allocation of funds for
new recycling bins and trash cans.
The senators of SGA approved an al
location of $1500.00 toward a new I.D. sys
tem. If Brevard College purchases a new
I.D. system, there could be additions to the
use of the I.D. For example, an added use
could be swiping an I.D. to get into dormi
tories.
Talk of a purchasing a poster maker is
going around the senate. No money as of
yet has been allocated toward purchasing
one. More information is needed to make a
final decision.
The new SGA constitution has not
been put into affect and will not be in use
by the time the new SGA executive board
takes office on Wednesday, March 16,2005.
If anyone has any questions about the new
SGA constitution, e-mail Kody Kinsley.
Any questions about course not
taught or not taught regularly that you
would like to see? E-mail Sarah Lange.
The Student Institutional Relations
committee stated that there is going to be a
graduated increase in parking tickets fines.
For example, a first offense will be $30, the
next will be $40.
The IPAC committee discussed the al
cohol policy on campus and its effective
ness. The addition of a football team as a
possibility was also discussed.
$200 was allocated toward food for the
faculty and staff for faculty and staff ap
preciation day. Therewillbeadaysetas.de
for this in the future. The food will be put in
lobbies of the campus buildings.
The Senators of SGA approved an al
location of $500 for updating pictures dis
played on campus. Older photographs will
be archived.
March 16, 2005;
The new executive board was sworn
in.
The senators of SGA approved to split
the cost $545 with residence life for pur
chasing carabineers. SGA will pay $275.
They will be given out to all current resi
dence students and incoming freshman
who plan to live on campus. They will say
“Compliments of SGA and Residence Life.”
Chris Dimond was welcomed as the
new Organizational Committee Chair.
Chemistry Club hosts guest speaker
Even af^er the drug’s approval, there Audia s.
By Daniel Cureton -ill effects that come up after the coun ess c^
I Cureton
Staff Writer
Ms. Vickie Audia came to Brevard
College on Thursday March 17, 2005 to
talk to the Chemistry club and Tri Beta
about the opening of U.S borders to
importation of foreign pharmaceutical
medicines.
Audia described, in detail, the
process a drug company has to go
through to get its drug out on the market.
According to Audia, these companies
first have to research the drug, which
takes an average of 1.5 years. Clinical
research and development can take an
average of 5 years. New drug application
review, which is the submission and
approval after the research phase, takes
and average of two years. Finally, the
post marketing survey, which includes
adverse reactions, survey sampling and
inspections, can take several years to
moat It «
—^^aii iiK.c several ycaia v'-'
meet the standards of the FDA. people
Even after the drug’s approval, there
are still side effects that come up after the
drug is on the market, according to Audia.
Vioxx had no problems when it came onto
the market, but when people started to
misuse the drug, unknown side effects
were produced.
Audia next discussed the “Age of
Computers” and placing online orders^
With online orders, she talked about t e
National Association of Boards of
Pharmacy, whose purpose is developing,
implementing, and enforcing uniform
standards for the purpose of protecting
the public health.
According to Audia, it is illegal
buy drugs and import them into the
United States, although there are special
exceptions to this rule. For example, if
you need a drug for cancer that is on y
available in England, then the U.S. will let
you buy it as long as it is non toxic and
Lnnot be distributed to large groups of
Audia said that there have been
countless cases of foreign medicines
coming to the U.S. pretending to be U.S.
medicines. One case occurred when 4
million pills of Lipitor where stopped from
entering the U.S. because of funny
labeling. With all the well kept records
that the FDA requires companies to keep,
the makers of Lipitor were able to prove
they did not make the medicine. In fact, it
did not even have the right medicine in it
to begin with.
According to Audia, the biggest
problem the FDA has with foreign
medicines is that they do not know the
standards of the makers, how they were
produced, what equipment and etc.
Audia said that if the U.S. were to
open its borders, the FDA would have to
go in and upgrade the standards of the
makers of these medicines to the level of
theU.S.,and, in turn, the cost would rise
just as if the medicines were produced in
the U.S.